The University of Sydney at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

The University of Sydney brings 5 presentations from 4 research groups to ASHG 2026 in Montréal. Its program centres on cancer risk and detection, ancestry-linked disease, and rare genetic disorders and therapies at this meeting. Genomics and Precision Health evaluates polygenic risk scores for screening four cancers, Ancestry and Health Genomics Lab links prostate-tumour features to ancestry and geography, and Molecular Neurobiology defines variant-specific tubulinopathy mechanisms.

Organization	ASHG 2026 Attendance
The University of Sydney Sydney, Australia	3 PhD Students · 1 PI
Ancestry and Health Genomics Labsydney.edu.au/medicine-health/our-research/research-centres/ancestry-and-health-genomics-lab.html Wet + dry lab~20 people Uses tumour whole-genome, transcriptome and epigenome data, long-read sequencing and optical genome mapping. Studies ancestry-linked prostate-cancer disparities with the Sydney Informatics Hub. 65 papers since 2024 › The Germline and Somatic Origins of Prostate Cancer Heterogeneity Cancer Discovery, 2025 Health Equity Research Outcomes and Improvement Consortium Prostate Cancer Health Precision Africa1K: Closing the Health Equity Gap Through Rural Community Inclusion Journal of Urologic Oncology, 2024 Charting a landmark-driven path forward for population genetics and ancient DNA research in Africa The American Journal of Human Genetics, 2024 Source: OpenAlex author A5030507591 15 platforms and techniques › Works with Bionano Saphyr gen2, Optical genome mapping, Digital karyotyping, Long-read sequencing, Short-read sequencing, Whole-genome sequencing, Transcriptomic workflows, Tumour-derived DNA methylation Techniques Telomere-to-telomere genome finishing, Pangenome analysis, Machine learning, Quantum computing, Multi-omic integration, Exposomics, Polygenic risk scoring Source: lab pages No funding stated · No openings posted	Talk Fri Oct 23 11:45 am Part of What's Next in Genetics and Genomics: Late Breaking Science Differentiate molecular hallmarks in prostate tumours linking ancestry and geography Room 517BC/Level 5 Collaborators: University of Manchester, University of Pretoria +5 more CancerComputational toolsGene environment interactionPrecision medicine
Genomics and Precision Healthdaffodilcentre.org/streams/genomics-and-precision-health Dry lab~8 people Integrates individual and population-level genomic, health, and demographic information. Evaluates multi-cancer detection tests for risk-based cancer screening and early detection. 40 papers since 2024 › The global impact of the COVID-19 pandemic on delays and disruptions in cancer care services: a systematic review and meta-analysis Nature Cancer, 2025 The Cost Effectiveness of Genomic Medicine in Cancer Control: A Systematic Literature Review Applied Health Economics and Health Policy, 2025 Mainstreaming Cancer Genomic Testing: A Scoping Review of the Acceptability, Efficacy, and Impact Clinical Genetics, 2024 Source: OpenAlex author A5079865615 Funded by Australian Government Medical Research Future Fund, Medical Research Future Fund +1 more › Australian Government Medical Research Future Fund, Australian Cancer Risk Study · active “This research program is funded by a $3M grant from the Australian government’s Medical Research Future Fund (MRFF)” Medical Research Future Fund, MCD Spotlight · active “our team leads MCD Spotlight, a $3M MRFF-funded collaborative research program” Cancer Institute NSW, Career Development Fellowship · active “as part of A/Prof. [name]’s Cancer Institute NSW Career Development Fellowship” Source: lab pages 9 platforms and techniques › Analyzes Multi-cancer detection tests Techniques Cancer risk prediction, Risk-based cancer screening, Multi-cancer detection test evaluation, Large-scale health-data analysis, Microsimulation modelling, Health economic evaluation, Implementation studies and trials, Pan-tumour biomarker burden forecasting Source: lab pages No openings posted	Session Wed Oct 21 1:30 pm Advancing Precision Oncology with AI, Functional Genomics, and Multi-Omics: From Risk Prediction to Tumor Evolution and Therapeutic Discovery Room 510/Level 5 Poster Thu Oct 22 4:15 pm Part of Cancer Poster Thursday Session Evaluating of the potential of polygenic risk scores to inform risk-based screening for four major cancers: modelled benefits, harms, costs and cost-effectiveness for a range of different scenarios Exhibit & Poster Hall · Board 1021T Collaborators: Cancer Australia, Adelaide University +1 more CancerPolygenic risk scorePublic health
Molecular Neurobiologykr.schn.health.nsw.gov.au/our-research/neuroscience/kids-neuroscience-centre/research-groups/molecular-neurobiology Wet lab~11 people Develops gene therapies using cortical brain organoids, stem-cell technologies and bioinformatic computational tools. Targets Rett syndrome and rare monogenic neurodevelopmental disorders. 15 papers since 2024 › Epigenetic, ribosomal, and immune dysregulation in paediatric acute-onset neuropsychiatric syndrome Molecular Psychiatry, 2025 Rett syndrome Nature Reviews Disease Primers, 2024 Ketogenic diet modifies ribosomal protein dysregulation in KMT2D Kabuki syndrome EBioMedicine, 2024 Source: OpenAlex author A5003074211 Funded by NHMRC › NHMRC, Ideas Grant · 2026 “awarded $1,710,000 (NHMRC Ideas Grant) to conduct a novel multi-isoform gene therapy approach for neurodevelopmental disorders.” Source: lab pages 6 platforms and techniques › Techniques cortical brain organoids, stem cell technologies, bioinformatic computational tools, patient-cell conversion to stem cells, gene therapies, multi-isoform gene therapy Source: lab pages No openings posted	Poster Wed Oct 21 2:30 pm Part of Molecular Effects of Genetic Variation Poster Wednesday Session Defining variant-specific tubulinopathy molecular mechanisms in malformations of cortical development (MCDs) Exhibit & Poster Hall · Board 6022W Collaborators: Swansea University, University of Washington +1 more Protein structureNeurodevelopmentalMalformationGenetic variation
Translational Neurogenomics Research Groupkr.schn.health.nsw.gov.au/our-research/neuroscience/kids-neuroscience-centre/research-groups/translational-neurogenomics Wet + dry lab~5 people Studies neurological disorders with whole-genome/exome sequencing, 3D model systems and high-throughput in-vitro functional assays. Focuses on hyperekplexia, epilepsy and rare genetic disease mechanisms. Funded by National Health and Medical Research Council (NHMRC) › National Health and Medical Research Council (NHMRC), Ideas Grant · 2021 “[name] has been awarded $586,000 for Characterisation of novel genetic variants in Hyperekplexia and Dravet Syndrome: Identifying the Unknown Knowns” Source: lab pages 13 platforms and techniques › Works with whole-genome sequencing, whole-exome sequencing, next-generation sequencing, 3D model systems, high-throughput in-vitro functional assays, brain organoids, cellular live-cell imaging Techniques in-vitro functional characterisation, alternative splicing analysis, 3D protein modelling, protein characterisation, computer-based structural modelling, 3D model systems Source: lab pages No openings posted	Poster Thu Oct 22 4:15 pm Part of Molecular Effects of Genetic Variation Poster Thursday Session Aberrant splicing across glycinergic genes underlies human hyperekplexia Exhibit & Poster Hall · Board 6003T Collaborators: Swansea University Alternative splicingNeurogeneticsSplicing mechanismsGenetic variation
1 more presenter — research group not yet identified

Instantly find 20 buyers from The University of Sydney

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction